The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs

Journal of Drug Delivery Science and Technology

Volumn 14, Issue 1, 2004, Pages 35-43

  Loftsson, T ^a   Masson M ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Complexation efficacy; Cyclodextrin; Drug delivery; Drug formulation; Polymer; Solubility; Ternary complex

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETAZOLAMIDE; ALPRAZOLAM; BETA CYCLODEXTRIN DERIVATIVE; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CARBONATE DEHYDRATASE INHIBITOR; CARBOXYMETHYLCELLULOSE; CYCLODEXTRIN DERIVATIVE; DEXAMETHASONE; DEXOCORT; DORZOLAMIDE; DRUG; ESTRADIOL; EYE DROPS; GLIBENCLAMIDE; HEXADIMETHRINE BROMIDE; HYDROCORTISONE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; METHAZOLAMIDE; METHYLCELLULOSE; MIDAZOLAM; POLYMER; POVIDONE; RUFLOXACIN; TOOTHPASTE; TRICLOSAN; TROPICAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER; WATER SOLUBLE POLYMER;

ADHESION; AQUEOUS SOLUTION; CHEEK MUCOSA; CLINICAL TRIAL; COMPLEX FORMATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUBILITY; HUMAN; MEMBRANE PERMEABILITY; MOLECULAR INTERACTION; MOUTHWASH; NONHUMAN; REVIEW; STOICHIOMETRY; SUSTAINED DRUG RELEASE; TABLET;

EID: 1842451466     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-2247(04)50003-5     Document Type: Review

References (78)

1. LOFTSSON T., BREWSTER M.E. - Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. - J. Pharm. Sci., 85 (10), 1017-1025, 1996.
2. STELLA V.J., RAJEWSKI R.A. - Cyclodextrins: their future in drug formulation and delivery. - Pharm. Res., 14 (5), 556-567, 1997.
3. RAJEWSKI R.A., STELLA V.J. - Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. - J. Pharm. Sci., 85 (11), 1142-1168, 1996.
4. PITHA J., MILECKI J., FALES H., PANNELL L., UEKAMA K. - Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs. - Int. J. Pharm., 29, 73-82, 1986.
5. LOFTSSON T., MATTHÍASSON K., MÁSSON M. - The effects of organic salts on the cyclodextrin solubilization of drugs. - Int. J. Pharm., (in print), 2003.
6. LOFTSSON T., BREWSTER M.E., DERENDORF H., BODOR N. - 2-hydroxypropyl-b-cyclodextrin: Properties and usage in pharmaceutical formulations. - Pharm. Ztg. Wiss., 136, 5-10, 1991.
7. LOFTSSON T., MÁSSON M., SIGURJÓNSDÓTTIR J.F. - Methods to enhance the complexation efficiency of cyclodextrins. - STP Pharma Sci., 9, 237-242, 1999.
8. RAO V.M., STELLA V.J. - When can cyclodextrins be considered for solubilizing purposes? - J. Pharm. Sci., 92, 927-932, 2003.
9. LOFTSSON T. - Cyclodextrins and the biopharmaceutics classification system. - J. Incl. Phenom. Macroc. Chem., 44, 63-67, 2002.
10. LOFTSSON T., FRIDRIKSDOTTIR H., SIGURDARDOTTIR A.M., UEDA H. - The effect of water-soluble polymers on drug-cyclodextrin complexation. - Int. J. Pharm., 110, 169-177, 1994.
11. LOFTSSON T. - Effects of cyclodextrins on the chemical stability of drugs in aqueous solutions. - Drug Stability, 1(1), 22-33, 1995.
12. RILEY C.M., RYTTING J.H., KRAL M.A. (Eds.) -Takeru Higuchi, a Memorial Tribute, Volume 3, Equilibria and Thermodynamics. - Allen Press, Lawrence, 1991.
13. TOMASIK P., SCHILLING C.H. - Complexes of starch with organic guests - In: Advances in Carbohydrate Chemistry and Biochemistry, D. Horton Ed., Academic Press, San Diego, 1998, pp. 345-426.
14. LOFTSSON T., FRIDRIKSDOTTIR H., GUDMUNDSDOTTIR T.K. - The effect of water-soluble polymers on aqueous solubility of drugs. - Int. J. Pharm., 127, 293-296, 1996.
15. RÁCZ I. - Drug Formulations. - John Wiley and Sons, Budapest, 1989.
16. GABELICA V., GALIC N., DE PAUW E. - On the specificity of cyclodextrin complexes detected by electrospray mass spectrometry. - J. Am. Soc. Mass Spectrom., 13, 946-953, 2002.
17. KOMIYAMA M., HIRAI H., KOBAYASHI K. - Complex-forming ability of linear glucose oligomers as noncyclic analogs of cyclodextrins. - Makromol. Chem. Rapid Commun., 7, 739-742, 1986.
18. AOYAMA Y., OTSUKI J., NAGAI Y., KOBAYASHI K., TOI H. - Host-guest complexation of oligosaccharides: interaction of maltodextrins with hydrophobic fluorescence probes in water. - Tetrahedron Lett., 33, 3775-3778, 1992,
19. KANO K., MINAMI K., HORIGUCHI K., ISHIMURA T., KODERA M. - Ability of non-cyclic oligosaccharides to form molecular complexes and its use for chiral separation by capillary zone electrophoresis. - J. Chromatogr. A, 694, 307-313, 1995.
20. BETTINETTI G., SORRENTI M., NEGRI A., SETTI M., MURA P., MELANI F. - Interaction of naproxen with alpha-cyclodextrin and its non-cyclic analog maltohexaose. - Pharm. Res., 16, 689-694, 1999.
21. TOMASIK P., SCHILLING C.H. - Complexes of starch with inorganic guests - In: Advances in Carbohydrate Chemistry and Biochemistry, D. Horton Ed., Academic Press, San Diego, 1998, pp. 263-343.
22. HARADA A. - Design and construction of supramolecular architectures consisting of cyclodextrins and polymers. - Adv. Polym. Sci., 133, 141-191, 1997.
23. SZEJTLI J. - Cyclodextrin Technology. - Kluwer Academic Publisher, Dordrecht, 1988.
24. HLADON T., CWIERTINA B. - Physical and chemical interaction between cellulose ethers and b-cyclodextrins. - Pharmazie, 49, 497-500, 1994.
25. VALERO M., PÉREZ-REVUELTA B.I., RODRÍGUEZ L.J. - Effect of PVP K-25 on the formation of naproxen:b-ciclodextrin complex. - Int. J. Pharm., 253, 97-110, 2003.
26. FAUCCI M.T., MURA P. - Effect of water-soluble polymers on naproxen complexation with natural and chemically modified b-cyclodextrins. - Drug Devel. Ind. Pharm., 27, 909-917, 2001.
27. MURA P., FAUCCI M.T., BETTINETTI G.P. - The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-b-cyclodextrin. - Eur. J. Pharm. Sci., 13, 187-194, 2001.
28. WANG Q., RUI X., ZHAO Z., GUO J., SU D. - Influence of PVP and PEG on pyroxicam b-cyclodextrin inclusion action. - Shenyang Yaoke Daxue Xuebao, 17, 240-242, 2000.
29. ÁLVAREZ C., VAN HEES T., PIEL G., LIÉGEOIS J.-F., DELATTRE L., EVRARD B.- Preparation of mebendazole HP-β-cyclodextrin complexes using water-soluble polymers and organic salts. - STP Pharma Sci., 11, 439-442, 2001.
30. YAMAKAWA T., NISHIMURA S. - Liquid formulation of a novel non-fluorinated topical quinolon, T-3912, utilizing the synergic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-β -cyclodextrin. - J. Control. Rel., 86, 101-113, 2003.
31. REDENTI E., SZENTE L., SZEJTLI J. - Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications. - J. Pharm. Sci., 89, 1-8, 2000.
32. REDENTI E., SZENTE L., SZEJTLI J. - Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications. - J. Pharm. Sci., 90, 979-986, 2001.
33. LOFTSSON T., BODOR N. - Effects of 2-hydroxypropyl-β-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17β-estradiol. - Acta Pharm. Nord., 1, 185-193, 1989.
34. KRISHNAMOORTHY R., MITRA A.K. - Complexation of weak acids and basis with cyclodextrins: Effects of substrate ionization on the estimation and interpretation of association constants. - Int. J. Pharm. Advances, 1, 330-343, 1996.
35. LOFTSSON T., GUMUNDSDÓTTIR T.K., and FRIRIKSDÓTTIR H. - The influence of water-soluble polymers and pH on hydroxypropyl-β -cyclodextrin complexation of drugs. - Drug Devel. Ind. Pharm., 22, 401-405, 1996.
36. POSE-VILARNOVO B., RODRÍGUEZ-TENREIRO SÁNCHEZ C., PÉREZ-MARCOS M.B., TORRES-LABANDEIRA J.J. - Sulphamethoxazole-cyclodextrin-hydroxy propylmethyl cellulose multicomponent complexes. - J. Therm. Anal. Cal., 68, 657-667, 2002.
37. LOFTSSON T. - Pharmaceutical applications of β-cyclodextrin. - Pharm. Technol., 23(12), 40-50, 1999.
38. LOFTSSON T., FRIRIKSDÓTTIR H. - The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin. - Int. J. Pharm., 163, 115-121, 1998.
39. KRISTMUNDSDÓTTIR T., LOFTSSON T., HOLBROOK W.P. - Formulation and clinical evaluation of a hydrocortisone solution for treatment of oral disease. - Int. J. Pharm., 139, 63-68, 1996.
40. HOLBROOK W.P., KRISTMUNDSDÓTTIR T., LOFTSSON T. - Aqueous hydrocortisone mouthwash solution: clinical evaluation. - Acta Odontol. Scand., 56, 157-160, 1998.
41. LOFTSSON T., LEEVES N., SIGURJÓNSDÓTTIR J.F., SIGURSSON H.H., MÁSSON M. - Sustained drug delivery system based on a cationic polymer and an anionic drug/ cyclodextrin complex. - Pharmazie, 56, 746-747, 2001.
42. SIGURSSON H.H., KNUDSEN E., LOFTSSON T., LEEVES N., SIGURJÓ NSDÓTTIR J.F., MÁSSON M. - Mucoadhesive sustained drug delivery system based on cationic polymer and anionic cyclodextrin/triclosan complex. - J. Incl. Phenom. Macroc. Chem., 44, 169-172, 2002.
43. MAREN T.H. - Process for reducing intraocular pressure - United States Patent 4,619,939, 1986.
44. LOFTSSON T., STEFÁNSSON E., KRISTINSSON J.K., FRIRIKSDÓ TTIR H., SVERRISSON T., GUMUNDSDÓTTIR G., THÓRISDÓTTIR S. - Topically effective acetazolamide eye-drop solution in man. - Pharm. Sci., 2, 277-279, 1996.
45. GUMUNDSDÓTTIR E., STEFÁNSSON E., BJARNADÓTTIR G., SIGURJÓNSDÓTTIR J.F., GUMUNDSDÓTTIR G., MÁSSON M., LOFTSSON T. - Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypotension. - Invest. Ophthalmol. Vis. Sci., 41, 3552-3554, 2000.
46. LOFTSSON T., FRIRIKSDÓTTIR H., STEFÁNSSON E., THÓRISDÓTTIR S., GUMUNDSSON Ö., SIGTHÓRSSON T. - Topically effective ocular hypertensive acetazolamide and ethoxyzolamide formulations in rabbits. - J. Pharm. Pharmacol., 46, 503-504, 1994.
47. LOFTSSON T., FRIDRIKSDOTTIR H., THORISDOTTIR S., STEFANSSON E., SIGURDARDOTTIR A.M., GUDMUNDSSON O., SIGTHORSSON T. - 2-Hydroxypropyl-β -cyclodextrin in topical carbonic anhydrase inhibitor formulations. - Eur. J. Pharm. Sci., 1, 175-180, 1994.
48. FRIRIKSDÓTTIR H., LOFTSSON T., STEFÁNSSON E. - Formulation and testing of methazolamide eye drop solutions. - J. Contr. Rel., 44, 95-99, 1997.
49. LOFTSSON T., STEFÁNSSON E., KRISTINSSON J.K., FRIRIKSDÓ TTIR H., SVERRISSON T., GUMUNDSDÓTTIR G., THÓRISDÓTTIR S. - Topically effective acetazolamide eye-drop solution in man. - Pharm. Sci., 6, 277-279, 1996.
50. SUGRUE M.F. - The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic an hydrase inhibitor. - J. Ocular Pharmacol. Therap., 12, 363-375, 1996.
51. KRISTINSSON J.K., FRIRIKSDÓTTIR H., THÓRISDÓTTIR S., SIGURARDÓTTIR A.M., STEFÁNSSON E., LOFTSSON T. - Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. - Invest. Ophthalmol. Vis. Sci., 37, 1199-1203, 1996.
52. LOFTSSON T., STÉFANSSON E. - Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. - Acta Ophthalmol. Scand., 80, 144-150, 2002.
53. STEFÁNSSON E., LOFTSSON T. - Cyclodextrins in eye drop formulations. - J. Incl. Phenom. Macroc. Chem., 44, 23-27, 2002.
54. LOFTSSON T., STEFÁNSSON E. - Effect of cyclodextrins on topical drug delivery to the eye. - Drug Devel. Ind. Pharm., 23, 473-481, 1997.
55. SAARI K.M., JYRKKIÖ H., SEPPÄ H., LOFTSSON T., STEFANSSON E. - Acute and chronic postoperative inflammatory reactions after cateract extraction and intraocular lens implantation. - Uveitis Today, 1158, 99-102, 1998.
56. th International Cyclodextrin Symposium, Wacker Biochem Corporation, Ann Arbor, 2000.
57. CAPPELLO B., IERVOLINO M., MIRO A., CHETONI P., BURGALASSI S., SAETTONE M.F. - Fornulation and preliminary in vivo testing of rufloxacin-cyclodextrin ophthalmic solutions. - J. Incl. Phenom. Macroc. Chem., 44, 173-176, 2002.
58. LEE V.H.L., ROBINSON J.R. - Topical ocular drug delivery: recent developments and future challenges. - J. Ocul. Pharmacol., 2, 67-108, 1986.
59. CAPPELLO B., CARMIGNANI C., IERVOLINO M., ROTONDA M.I.L., SAETTONE M.F. - Solubilization of tropicamide by hydroxypropyl-β-cyclodextrin and water-soluble polymers: in vitro/in vivo studies. - Int. J. Pharm., 213, 75-81, 2001.
60. LOFTSSON T., GUDMUNDSDOTTIR H., SIGURJONSDOTTIR J.F., SIGURDSSON H.H., SIGFUSSON S.D., MASSON M., STEFANSSON E. - Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. - Int. J. Pharm., 212, 29-40, 2001.
61. GUDMUNDSDOTTIR H., SIGURJONSDOTTIR J.F., MASSON M., FJALLDAL O., STEFANSSON E., LOFTSSON T. - Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. - Pharmazie, 56, 963-966, 2001.
62. FRIRIKSDÓTTIR H., LOFTSSON T., GUMUNDSSON J.A., BJARNASON G.J., KJELD M., THORSTEINSSON T. - Design and in vivo testing of 17β -estradioI-HPβCD sublinqual tablets. - Pharmazie, 51, 39-42, 1996.
63. LOFTSSON T., GUMUNDSSON J.A., ÁRNADÓTTIR R.O., FRIRIKSDÓTTIR H. - Sublingual delivery of 17β-estradiol from cyclodextrin containing tablets. - Pharmazie, 58, 358-359, 2003.
64. LOFTSSON T., LEEVES N., BJORNSDOTTIR B., DUFFY L., MASSON M. - Effect of cyclodextrins and polymers on triclosan availability and substantivity in toothpastes in vivo. - J. Pharm. Sci., 88, 1254-1258, 1999.
65. SAVOLAINEN J., JÄRVINEN K., TAIPALE H., JARHO P., LOFTSSON T., JÄRVINEN T. - Coadministration of a water-soluble polymer increases the usefulness of cyclodextrins in solid dosage forms. - Pharm. Res., 15, 1696-1701, 1998.
66. LOFTSSON T., MASSON M. - Cyclodextrins in topical drug formulations: theory and practice. - Int. J. Pharm., 225, 15-30, 2001.
67. MASSON M., LOFTSSON T., MASSON G., STEFANSSON E. - Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. - J. Control. Rel., 59, 107-118, 1999.
68. LOFTSSON T., SIGFÚSSON S.D., SIGURSSON H.H., MÁSSON M. - The effects of cyclodextrins on topical delivery of hydrocortisone: the aqueous diffusion layer. - STP Pharma Sci., 13, 125-131, 2003.
69. LOFTSSON T., SIGURARDOTTIR A.M. - The effect of polyvinylpyrrolidone and hydroxypropyl methylcellulose on HPβCD complexation of hydrocortisone and its permeability through hairless mouse skin. - Eur. J. Pharm. Sci., 2, 297-301, 1994.
70. SIGURDARDOTTIR A.M., LOFTSSON T. - The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. - Int. J. Pharm., 126, 73-78, 1995.
71. LOFTSSON T., PETERSEN D.S. - Cyclodextrin solubilization of water-insoluble drugs: calcipotriol and EB-1089. - Pharmazie, 52, 783-786, 1997.
72. WU W., CHEN W., TAN Z. - Effects of water-soluble polymers on drug-cyclodextrin complexation. - Zhongguo Yaoxue Zazhi (Beijing), 34, 99-101, 1999.
73. LOFTSSON T., FRIRIKSDOTTIR H., THORISDOTTIR S., STEFANSSON E. - The effect of hydroxypropyl methylcellulose on release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. - Int. J. Pharm., 104, 181-184, 1994.
74. AGGARWAL S., SINGH RN., MISHRA B. - Studies on solubility and hypoglycemic activity of gliclazide β -cyclodextrin-hydroxy-propylmethylcellulose complexes. - Pharmazie, 57, 191-193, 2002.
75. BREWSTER M.E., ANDERSON W.R., LOFTSSON T., HUANG M.-J., BODOR N., POP E. - Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-β-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. - J. Pharm. Sci., 84, 1154-1159, 1995.
76. JARHO P., PATE D.W., BRENNEISEN R., JÄRVINEN T. - Hydroxypropyl-β-cyclodextrin and its combination with hydroxypropyl methylcellulose increases aqueous solubility of D9-tetrahydrocannabinol. - Life Sci., 63(26), PL381-PL384, 1998.
77. RIBEIRO L., VEIGA F. - Complexation of vinpocetine by cyclodextrins in the presence or absence of polymers. Binary and ternary complexes preparation and characterization. - J. Incl. Phenom. Macroc. Chem., 44, 251-256, 2002.
78. LOFTSSON T., MASSON M., SIGURDSSON H.H., MAGNUSSON P., GOFFIC F.L. - Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. - Pharmazie, 53, 137-139, 1998.